Office of the Secretary; Notice of Meeting, 19766 [2020-07414]

Download as PDF 19766 Federal Register / Vol. 85, No. 68 / Wednesday, April 8, 2020 / Notices The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Women’s Health Initiative Renewal. Date: April 30, 2020. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: NIH RKL 1, 6705 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National, Heart, Lung, and Blood Institute, 6705 Rockledge Drive, Bethesda, MD 20892, 301–827–7987, susan.sunnarborg@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: April 3, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. advocacy groups, other voluntary health organizations, and patients and their families to update one another on progress relevant to the Action Plan for the Muscular Dystrophies and to coordinate activities and discuss gaps and opportunities leading to better understanding of the muscular dystrophies, advances in treatments, and improvements in patients’ and their families’ lives. Prior to the meeting, an agenda will be posted to the MDCC meeting registration website: https:// meetings.ninds.nih.gov/meetings/MDCC2020. Registration: To register, please go to: https://meetings.ninds.nih.gov/Home/ Registration/26698. Webcast Live: https://nih.webex.com/nih/ onstage/g.php?MTID=e1c2d0bed65aa 419911386eaa2ea2bb42. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Blvd., Bethesda, MD 20892 (Video Assisted Meeting). Contact Person: Glen Nuckolls, Ph.D., Program Director, NINDS/NIH, Neuroscience Center, 6001 Executive Blvd., Rm 2203, Bethesda, MD 20892, 301–496–5876, nuckollg@ninds.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. More information can be found on the Muscular Dystrophy Coordinating Committee home page: https://mdcc.nih.gov/. Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01). Date: May 13, 2020. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergies and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G42, Rockville, MD 20892, (Telephone Conference Call). Contact Person: Sandip Bhattacharyya, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergies and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G42, Rockville, MD 20852, sandip.bhattacharyya@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: April 2, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2020–07414 Filed 4–7–20; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2020–07407 Filed 4–7–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting lotter on DSKBCFDHB2PROD with NOTICES Office of the Secretary; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Muscular Dystrophy Coordinating Committee (MDCC). The meeting will be open to the public. Individuals who plan to participate and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Muscular Dystrophy Coordinating Committee. Date: June 8, 2020. Time: 1:00 p.m. to 4:00 p.m. Agenda: The purpose of this meeting is to bring together committee members, representing government agencies, patient VerDate Sep<11>2014 18:37 Apr 07, 2020 Jkt 250001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Dated: April 2, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–07409 Filed 4–7–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Initial Review Group; Pediatrics Subcommittee. Date: June 4, 2020. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Child Health and Human Development, 6710B Rockledge Drive, Rm. 2125C, Bethesda, MD 20892–7002 (Telephone Conference Call). E:\FR\FM\08APN1.SGM 08APN1

Agencies

[Federal Register Volume 85, Number 68 (Wednesday, April 8, 2020)]
[Notices]
[Page 19766]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07414]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Muscular Dystrophy 
Coordinating Committee (MDCC).
    The meeting will be open to the public. Individuals who plan to 
participate and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Date: June 8, 2020.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups, other voluntary health organizations, and patients 
and their families to update one another on progress relevant to the 
Action Plan for the Muscular Dystrophies and to coordinate 
activities and discuss gaps and opportunities leading to better 
understanding of the muscular dystrophies, advances in treatments, 
and improvements in patients' and their families' lives. Prior to 
the meeting, an agenda will be posted to the MDCC meeting 
registration website: https://meetings.ninds.nih.gov/meetings/MDCC2020.
    Registration: To register, please go to: https://meetings.ninds.nih.gov/Home/Registration/26698.
    Webcast Live: https://nih.webex.com/nih/onstage/g.php?MTID=e1c2d0bed65aa419911386eaa2ea2bb42.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Blvd., Bethesda, MD 20892 (Video Assisted Meeting).
    Contact Person: Glen Nuckolls, Ph.D., Program Director, NINDS/
NIH, Neuroscience Center, 6001 Executive Blvd., Rm 2203, Bethesda, 
MD 20892, 301-496-5876, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    More information can be found on the Muscular Dystrophy 
Coordinating Committee home page: https://mdcc.nih.gov/.

    Dated: April 2, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-07414 Filed 4-7-20; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.